why does nobody talk about Apotheke
why does nobody talk about Apotheke. I am not trying to be the "source?" guy. I would just like a source.
The structure that makes this board make sense, once.
Marketing authorisation for these products is granted centrally, which is why the same product exists across the union. Everything after that — whether it is reimbursed, on what criteria, at what price, in what pack size, dispensed under what margin rules — is decided nationally.
So "is it covered" has twenty-seven answers, "what does it cost" has twenty-seven answers plus within-country variation, and only "is it authorised" has one. Almost every argument on this board is two people answering different questions from different countries, both correctly.
How to compare prices across borders without misleading yourself.
Normalise the pack size first. Presentations differ between member states and a headline figure for one pack is not comparable to another. Then separate reimbursed from private prices, which are set by entirely different mechanisms. Then note the dispensing fee structure, which is nationally regulated.
When members here have done all three, the interesting finding has consistently been that variation between pharmacies within a country is often as large as the variation between countries — which makes the cross-border shopping most of these threads are really about far less attractive than it looks.
On cross-border prescriptions, since the assumption behind half these threads is wrong.
There are EU rules on the recognition of prescriptions issued in another member state, and they are conditional: the prescription has to meet requirements about its form and content, certain categories are excluded, and pharmacies retain discretion in practice.
The result is that "my prescription will be accepted anywhere in the EU" is not a safe assumption, and members here have discovered it at a counter in another country. If it matters for a trip, check before you travel with the pharmacy and with somebody qualified where you are. Nothing on this board is advice about that, and the rules are national in their application whatever the framework says.
I will update this if the picture changes rather than quietly leaving it up.
best — the order this archive was captured in
Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.
a shortage in one member state is not a shortage in all of them
a shortage in one member state is not a shortage in all of them
This is the split the whole board depends on. Authorisation is European; payment is national.
This is the split the whole board depends on.
Disagreeing with this bit: that criterion belongs to one member state and is being quoted as general.
EU-wide advice is almost always wrong somewhere
Small fix — those two prices are for different pack sizes, which accounts for most of the gap.
Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.
[deleted]
Is the prescription from the same country as the pharmacy?
Is the prescription from the same country as the pharmacy?
preservative_free_p is right about cross-border recognition being narrower than the summaries suggest.
Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.
Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.
Not convinced — cross-border prescription recognition is narrower than you are describing and the exceptions matter.
Adding the practical step — read your own country’s published criteria. They exist and they are definitive.
Agreed — authorisation is European, reimbursement is national, and almost every confused thread here misses that split.
Disagree. That is one member state’s reimbursement rule and it does not generalise across the union.
That shortage notice was national and does not apply where the question is coming from.
a prescription from one member state is not automatically valid in another
Correcting myself upthread: the criterion I quoted was updated for this year.
Kept the prescription and the receipt for a claim, purely because a thread here told me to. Both were requested.
- 1a shortage in one member state is not a shortage in all of them8 comments in this branch · started by u/patient_labslip_log